Cellular hypersensitivity to tuberculin in BCG-revaccinated persons studied by skin reactivity, leucocyte migration inhibition and lymphocyte proliferation. 1980

H Repo, and A A Kostiala, and T U Kosunen

Some persons seem to lose long-standing peripheral hypersensitivity to tuberculin earlier than others. This was seen in a group of five healthy student nurses who had been BCG-vaccinated as children and were found, in routine skin testing, to be negative to 100 TU of tuberculin purified protein derivative (PPD). They were revaccinated, which resulted in conversion to 10 TU skin test positivity. In agreement with this, their buffy coat cells achieved reactivity to 100 microgram/ml of PPD in a leucocyte migration inhibitory factor (LIF) assay. However, the LIF response, being maximal at 4 weeks, faded away earlier than skin reactivity. Peripheral blood lymphocyte proliferation was studied with several PPD concentrations, 10 microgram/ml always inducing the maximum 3H-thymidine uptake. This was still high at 6 months after vaccination, when the skin reactions tended to be smaller than earlier. The reason why the various parameters of cellular hypersensitivity followed different courses is not known, but it may involve different subpopulations of lymphocytes, activity of suppressor cells or influence by serum factors such as mycobacterial antigen-antibody complexes.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D007961 Leukocyte Migration-Inhibitory Factors Protein factor(s) released by sensitized lymphocytes (and possibly other cells) that inhibit the movement of LEUKOCYTES, especially polymorphonuclear cells, away from their site of release. Assays for these factors are used as tests for cellular immunity. Two of the common assays are the LEUKOCYTE MIGRATION CAPILLARY TUBE TECHNIQUE (LMCT) and the LEUKOCYTE MIGRATION AGAROSE TEST (LMAT). Migration-Inhibition Factors, Leukocyte,Leukocyte Migration-Inhibition Factors,Migration-Inhibitory Factors, Leukocyte,Factors, Leukocyte Migration-Inhibition,Factors, Leukocyte Migration-Inhibitory,Leukocyte Migration Inhibition Factors,Leukocyte Migration Inhibitory Factors,Migration Inhibition Factors, Leukocyte,Migration Inhibitory Factors, Leukocyte
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002464 Cell Migration Inhibition Phenomenon of cell-mediated immunity measured by in vitro inhibition of the migration or phagocytosis of antigen-stimulated LEUKOCYTES or MACROPHAGES. Specific CELL MIGRATION ASSAYS have been developed to estimate levels of migration inhibitory factors, immune reactivity against tumor-associated antigens, and immunosuppressive effects of infectious microorganisms. Chemotaxis Inhibition,Chemotaxis Inhibitions,Inhibition, Chemotaxis,Inhibitions, Chemotaxis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

H Repo, and A A Kostiala, and T U Kosunen
January 1979, Medycyna doswiadczalna i mikrobiologia,
H Repo, and A A Kostiala, and T U Kosunen
January 1967, Problemy tuberkuleza,
H Repo, and A A Kostiala, and T U Kosunen
January 1973, Avian pathology : journal of the W.V.P.A,
H Repo, and A A Kostiala, and T U Kosunen
December 1984, Journal of the Egyptian Society of Parasitology,
H Repo, and A A Kostiala, and T U Kosunen
December 1976, L'union medicale du Canada,
H Repo, and A A Kostiala, and T U Kosunen
August 1987, Allergy,
H Repo, and A A Kostiala, and T U Kosunen
January 1981, Journal of hygiene, epidemiology, microbiology, and immunology,
H Repo, and A A Kostiala, and T U Kosunen
March 1978, Clinical and experimental immunology,
H Repo, and A A Kostiala, and T U Kosunen
September 1973, Clinical and experimental immunology,
Copied contents to your clipboard!